Overview

  • Product nameAnti-Measles nucleoprotein antibody
    See all Measles nucleoprotein primary antibodies
  • Description
    Rabbit polyclonal to Measles nucleoprotein
  • Tested applicationsSuitable for: ELISA, WBmore details
  • Species reactivity
    Reacts with Measles virus. Not yet tested in other species.
  • Immunogen

    Recombinant full length protein.

Properties

Applications

Our Abpromise guarantee covers the use of ab23974 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA 1/2000 - 1/10000.
WB 1/200 - 1/1000. Predicted molecular weight: 58 kDa.

Target

  • RelevanceInvolved in the encapsidating of the genome in a ratio of 1 N per 6 ribonucleotides, resulting in the protection from nucleases. The nucleocapsid (NC) has an helical structure with either 12.35 or 11.64 N per turn, approximately 20nm in diameter, with a hollow central cavity approximately 5nm in diameter. The encapsidated genomic RNA is termed the NC and serves as template for transcription and replication. During replication, encapsidation by N is coupled to RNA synthesis and all replicative products are resistant to nucleases. N is released in the blood following lysis of measles infected cells, it interacts then with human FCGR2B on immune cells, inducing apoptosis and blocking inflammatory immune response. Ntail binds to a protein on human thymic epithelial cells, termed Nucleoprotein Receptor (NR), inducing growth arrest
  • Cellular localizationVirion. Host cytoplasm.
  • Alternative names
    • Measles nucleocapsid protein antibody
    • N antibody
    • NP antibody
    • Nucleocapsid protein antibody

References for Anti-Measles nucleoprotein antibody (ab23974)

This product has been referenced in:
  • Stewart CE  et al. Inhibitors of the interferon response enhance virus replication in vitro. PLoS One 9:e112014 (2014). Read more (PubMed: 25390891) »
  • Berchtold S  et al. Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis. J Virol 87:3484-501 (2013). Read more (PubMed: 23302892) »

See all 5 Publications for this product

Product Wall

There are currently no Abreviews or Questions for ab23974.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"